QA: TYME TECHNOLOGIES INC. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001537917_2022_TYME_TECHNOLOGIES_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001537917')"}

Graph

Absolute values for 0001537917, TYME TECHNOLOGIES INC.

  xvar xval
0 AssetsCurrent 109,656,860
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 606,460
4 LiabilitiesCurrent 5,643,785
5 LiabilitiesNoncurrent 41,256
6 remainder_Liabilities 2,782,630
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,185,537
9 ResearchAndDevelopmentExpense 17,031,474
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -1,761,752
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 110,263,320
1 Liabilities 8,467,671
2 Expenses 27,217,011
3 Revenues 0
4 StockholdersEquity 101,795,649
5 NetIncome -28,978,763
6 ComprehensiveNetIncome -28,978,763
7 BaseVar 73,854,877
8 EconomicCapitalRatio 2.46

Edgar->Model Mapping

Feature Distribution

Change over Time